person · Reporting owner

Tallett Elizabeth E

Disclosed activity across 5 companies

Tapewire entity: 48709
SEC CIK: 0001192460

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Elevance Health, Inc.ELV · Entity 2934	Director	May 15, 2024	May 17, 2024
Moderna, Inc.MRNA · Entity 2025	Director	May 06, 2026	May 08, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Elevance Health, Inc.

Report date May 15, 2024 · Filed May 17, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	10,291	Reported balance After 2024-05-15 transaction · row 1 1 source row Row 1 · 2024-05-15 · Grant · Acquired 388 · Balance 10,291 F1: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program.

F2: The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Moderna, Inc.

Report date May 06, 2026 · Filed May 08, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	8,371	Reported balance After 2026-05-06 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-05-06 · Grant · Acquired 8,371 · Balance 8,371 F1: Restricted stock units convert into common stock on a one-for-one basis. F2: The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: The shares subject to this restricted stock unit award will vest in full on the earlier of May 6, 2027, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.

Past disclosures · reporting ended (3)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Hawkeye Acquisition, Inc.

Report date December 01, 2021 · Filed December 03, 2021

Section 16 reporting ended · disclosed 2021-12-03. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock ($1 par value)SEC Table I · non-derivative	Direct	0	Reported balance After 2021-12-01 transaction · row 1 Sequence does not reconcile; account continuity is unresolved. 1 source row Row 1 · 2021-12-01 · Disposition to issuer · Disposed 28,915 · Balance 0 F1: In connection with the closing of the previously announced acquisition by Gray Television, Inc. ("Gray") of the issuer's local media group business immediately following and subject to the spin-off of the issuer's digital and magazine segments and corporate operations (collectively, the "Transactions") and as described in the issuer's definitive proxy statement filed with the Securities and Exchange Commission on November 8, 2021 (the "Proxy Statement"), each share of Common Stock was exchanged for (i) $16.99 in cash per share and (ii) shares of Common Stock of Meredith Holdings Corporation on a one-for-one basis.
Common Stock ($1 par value)SEC Table I · non-derivative	Direct	31,290	Reported balance After 2021-12-01 transaction · row 2 Sequence does not reconcile; account continuity is unresolved. 1 source row Row 2 · 2021-12-01 · Exercise / conversion · Acquired 4,697 · Balance 31,290
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.03 · Expires 2022-11-07	Direct	0	Reported balance After 2021-12-01 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2021-12-01 · Disposition to issuer · Disposed 8,100 · Balance 0 F2: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.29 · Expires 2023-11-06	Direct	0	Reported balance After 2021-12-01 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2021-12-01 · Disposition to issuer · Disposed 4,064 · Balance 0 F2: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.51 · Expires 2024-11-12	Direct	0	Reported balance After 2021-12-01 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2021-12-01 · Disposition to issuer · Disposed 3,912 · Balance 0 F2: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.51 · Expires 2025-11-11	Direct	0	Reported balance After 2021-12-01 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2021-12-01 · Disposition to issuer · Disposed 4,389 · Balance 0 F2: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.96 · Expires 2026-11-09	Direct	0	Reported balance After 2021-12-01 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2021-12-01 · Disposition to issuer · Disposed 5,685 · Balance 0 F2: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.06 · Expires 2027-11-08	Direct	0	Reported balance After 2021-12-01 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2021-12-01 · Disposition to issuer · Disposed 5,936 · Balance 0 F2: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.83 · Expires 2028-11-14	Direct	0	Reported balance After 2021-12-01 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2021-12-01 · Disposition to issuer · Disposed 4,697 · Balance 0 F2: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F1: In connection with the closing of the previously announced acquisition by Gray Television, Inc. ("Gray") of the issuer's local media group business immediately following and subject to the spin-off of the issuer's digital and magazine segments and corporate operations (collectively, the "Transactions") and as described in the issuer's definitive proxy statement filed with the Securities and Exchange Commission on November 8, 2021 (the "Proxy Statement"), each share of Common Stock was exchanged for (i) $16.99 in cash per share and (ii) shares of Common Stock of Meredith Holdings Corporation on a one-for-one basis. F4: Nonqualified stock options awarded pursuant to the Meredith Corporation 2014 Stock Incentive Plan, which become exercisable one-third per year over a three-year period beginning on the first anniversary of the grant date and expire on the tenth anniversary of the grant date.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $25.22 · Expires 2029-11-13	Direct	0	Reported balance After 2021-12-01 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2021-12-01 · Disposition to issuer · Disposed 8,161 · Balance 0 F2: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.33 · Expires 2030-11-11	Direct	0	Reported balance After 2021-12-01 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2021-12-01 · Disposition to issuer · Disposed 11,692 · Balance 0 F2: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option. F3: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Stock equivalent unitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2021-12-01 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2021-12-01 · Disposition to issuer · Disposed 25,282 · Balance 0 F5: In connection with the Transactions and as described in the Proxy Statement, these awards were canceled in exchange for (i) $16.99 in cash per share and (ii) stock equivalent units of Meredith Holdings Corporation with respect to an equal number of shares subject to these awards. F6: Pursuant to their original terms, the Stock Equivalent Units were convertible to Common Stock on a one-for-one basis upon the reporting person's resignation, retirement or other termination of service on the issuer's Board of Directors.

Filing footnotes · ownership attribution and instrument terms

F1: In connection with the closing of the previously announced acquisition by Gray Television, Inc. ("Gray") of the issuer's local media group business immediately following and subject to the spin-off of the issuer's digital and magazine segments and corporate operations (collectively, the "Transactions") and as described in the issuer's definitive proxy statement filed with the Securities and Exchange Commission on November 8, 2021 (the "Proxy Statement"), each share of Common Stock was exchanged for (i) $16.99 in cash per share and (ii) shares of Common Stock of Meredith Holdings Corporation on a one-for-one basis.

F2: In connection with the Transactions and as described in the Proxy Statement, the exercise price of this option was adjusted, which adjusted exercise price is reported in column 2 above, and this option was canceled in exchange for (i) a cash amount equal to the excess, if any, of $16.99 per share less the adjusted exercise price and (ii) a stock option of Meredith Holdings Corporation with respect to an equal number of shares subject to this option.

F3: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.

F4: Nonqualified stock options awarded pursuant to the Meredith Corporation 2014 Stock Incentive Plan, which become exercisable one-third per year over a three-year period beginning on the first anniversary of the grant date and expire on the tenth anniversary of the grant date.

F5: In connection with the Transactions and as described in the Proxy Statement, these awards were canceled in exchange for (i) $16.99 in cash per share and (ii) stock equivalent units of Meredith Holdings Corporation with respect to an equal number of shares subject to these awards.

F6: Pursuant to their original terms, the Stock Equivalent Units were convertible to Common Stock on a one-for-one basis upon the reporting person's resignation, retirement or other termination of service on the issuer's Board of Directors.

Meredith Holdings Corp

Report date December 01, 2021 · Filed December 03, 2021

Section 16 reporting ended · disclosed 2021-12-03. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock ($1 par value)SEC Table I · non-derivative	Direct	0	Reported balance After 2021-12-01 transaction · row 1 1 source row Row 1 · 2021-12-01 · Disposition to issuer · Disposed 28,915 · Balance 0 F1: The Reporting Person received these shares in the previously announced spin-off of Meredith Corporation's digital and magazine segments and corporate operations (the "Spin-Off"), described in the issuer's Registration Statement on Form 10 filed with the Securities and Exchange Commission on November 9, 2021 (the "Form 10"). The Spin-Off involved the pro rata distribution of shares of the issuer by Meredith Corporation to its shareholders on a one-for-one basis and the Spin-Off was consummated on December 1, 2021. The Reporting Person's receipt of such shares in the Spin-Off was exempt from reporting pursuant to Rule 16a-9. F2: In connection with the closing of the previously announced acquisition of the issuer by Dotdash Media Inc. (the "Merger") and as described in the Current Report on Form 8-K filed by Meredith Corporation, which was previously the issuer's parent company, on October 6, 2021 (the "8-K"), each share of Common Stock was exchanged for $42.18 in cash per share.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.03 · Expires 2022-11-07	Direct	8,100	Reported balance After 2021-12-01 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2021-12-01 · Grant · Acquired 8,100 · Balance 8,100 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.03 · Expires 2022-11-07	Direct	0	Reported balance After 2021-12-01 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2021-12-01 · Disposition to issuer · Disposed 8,100 · Balance 0 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.29 · Expires 2023-11-06	Direct	4,064	Reported balance After 2021-12-01 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2021-12-01 · Grant · Acquired 4,064 · Balance 4,064 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.29 · Expires 2023-11-06	Direct	0	Reported balance After 2021-12-01 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2021-12-01 · Disposition to issuer · Disposed 4,064 · Balance 0 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.51 · Expires 2024-11-12	Direct	3,912	Reported balance After 2021-12-01 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2021-12-01 · Grant · Acquired 3,912 · Balance 3,912 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.51 · Expires 2024-11-12	Direct	0	Reported balance After 2021-12-01 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2021-12-01 · Disposition to issuer · Disposed 3,912 · Balance 0 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.51 · Expires 2025-11-11	Direct	4,389	Reported balance After 2021-12-01 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2021-12-01 · Grant · Acquired 4,389 · Balance 4,389 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.51 · Expires 2025-11-11	Direct	0	Reported balance After 2021-12-01 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2021-12-01 · Disposition to issuer · Disposed 4,389 · Balance 0 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.06 · Expires 2027-11-08	Direct	5,936	Reported balance After 2021-12-01 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2021-12-01 · Grant · Acquired 5,936 · Balance 5,936 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.06 · Expires 2027-11-08	Direct	0	Reported balance After 2021-12-01 transaction · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · 2021-12-01 · Disposition to issuer · Disposed 5,936 · Balance 0 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.83 · Expires 2028-11-14	Direct	4,697	Reported balance After 2021-12-01 transaction · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · 2021-12-01 · Grant · Acquired 4,697 · Balance 4,697 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.83 · Expires 2028-11-14	Direct	0	Reported balance After 2021-12-01 transaction · row 15 Instrument identity requires review; Table II rows are not merged. 1 source row Row 15 · 2021-12-01 · Disposition to issuer · Disposed 4,697 · Balance 0 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $25.22 · Expires 2029-11-13	Direct	8,161	Reported balance After 2021-12-01 transaction · row 16 Instrument identity requires review; Table II rows are not merged. 1 source row Row 16 · 2021-12-01 · Grant · Acquired 8,161 · Balance 8,161 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $25.22 · Expires 2029-11-13	Direct	0	Reported balance After 2021-12-01 transaction · row 17 Instrument identity requires review; Table II rows are not merged. 1 source row Row 17 · 2021-12-01 · Disposition to issuer · Disposed 8,161 · Balance 0 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.33 · Expires 2030-11-11	Direct	11,692	Reported balance After 2021-12-01 transaction · row 18 Instrument identity requires review; Table II rows are not merged. 1 source row Row 18 · 2021-12-01 · Grant · Acquired 11,692 · Balance 11,692 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.33 · Expires 2030-11-11	Direct	0	Reported balance After 2021-12-01 transaction · row 19 Instrument identity requires review; Table II rows are not merged. 1 source row Row 19 · 2021-12-01 · Disposition to issuer · Disposed 11,692 · Balance 0 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Common Stock ($1 par value)SEC Table II · derivative / convertible security · Conversion / exercise price $33.96 · Expires 2026-11-09	Direct	5,685	Reported balance After 2021-12-01 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2021-12-01 · Grant · Acquired 5,685 · Balance 5,685 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F4: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Common Stock ($1 par value)SEC Table II · derivative / convertible security · Conversion / exercise price $33.96 · Expires 2026-11-09	Direct	0	Reported balance After 2021-12-01 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2021-12-01 · Disposition to issuer · Disposed 5,685 · Balance 0 F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price. F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.
Stock Equivalent UnitsSEC Table II · derivative / convertible security	Direct	25,282	Reported balance After 2021-12-01 transaction · row 20 Instrument identity requires review; Table II rows are not merged. 1 source row Row 20 · 2021-12-01 · Grant · Acquired 25,282 · Balance 25,282 F6: In connection with the Merger and as described in the 8-K, these awards were canceled in exchange for $42.18 in cash per share. F4: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person. F7: Pursuant to their original terms, the Stock Equivalent Units were convertible to Common Stock on a one-for-one basis upon the reporting person's resignation, retirement or other termination of service on the issuer's Board of Directors.
Stock Equivalent UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2021-12-01 transaction · row 21 Instrument identity requires review; Table II rows are not merged. 1 source row Row 21 · 2021-12-01 · Disposition to issuer · Disposed 25,282 · Balance 0 F6: In connection with the Merger and as described in the 8-K, these awards were canceled in exchange for $42.18 in cash per share. F7: Pursuant to their original terms, the Stock Equivalent Units were convertible to Common Stock on a one-for-one basis upon the reporting person's resignation, retirement or other termination of service on the issuer's Board of Directors.

Filing footnotes · ownership attribution and instrument terms

F1: The Reporting Person received these shares in the previously announced spin-off of Meredith Corporation's digital and magazine segments and corporate operations (the "Spin-Off"), described in the issuer's Registration Statement on Form 10 filed with the Securities and Exchange Commission on November 9, 2021 (the "Form 10"). The Spin-Off involved the pro rata distribution of shares of the issuer by Meredith Corporation to its shareholders on a one-for-one basis and the Spin-Off was consummated on December 1, 2021. The Reporting Person's receipt of such shares in the Spin-Off was exempt from reporting pursuant to Rule 16a-9.

F2: In connection with the closing of the previously announced acquisition of the issuer by Dotdash Media Inc. (the "Merger") and as described in the Current Report on Form 8-K filed by Meredith Corporation, which was previously the issuer's parent company, on October 6, 2021 (the "8-K"), each share of Common Stock was exchanged for $42.18 in cash per share.

F3: In connection with the Merger and as described in the 8-K, this option was canceled in exchange for a cash amount equal to the excess, if any, of $42.18 per share less the exercise price.

F4: In connection with the Spin-Off and as described in the Form 10, the Reporting Person received this award in partial consideration for the cancellation of an equity award of Meredith Corporation previously held by the Reporting Person.

F5: Pursuant to their original terms, the options were convertible to Common Stock on a one-for-one basis one-third per year over a three-year period beginning on the first anniversary of the grant date until completed on the third anniversary of the grant.

F6: In connection with the Merger and as described in the 8-K, these awards were canceled in exchange for $42.18 in cash per share.

F7: Pursuant to their original terms, the Stock Equivalent Units were convertible to Common Stock on a one-for-one basis upon the reporting person's resignation, retirement or other termination of service on the issuer's Board of Directors.

PRINCIPAL FINANCIAL GROUP INC

Report date June 25, 2021 · Filed June 29, 2021

Section 16 reporting ended · disclosed 2021-05-21. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Phantom Stock UnitsSEC Table II · derivative / convertible security	Direct	8,128	Reported balance After 2021-06-25 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2021-06-25 · Grant · Acquired 74 · Balance 8,128 F1: The units convert to common stock on a one-for-one basis. F2: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement.

Filing footnotes · ownership attribution and instrument terms

F1: The units convert to common stock on a one-for-one basis.

F2: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 25, 2021 Filed Jun 29, 2021 18:59 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantPhantom Stock Units · Derivative	74	$64.36	$4,762.64	Disclosure SEC source: 0001126328-21-000169 · edgar.xml · derivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,128 Underlying: Common Stock · 74 shares Expires not disclosed F1 · derivative.exercise_price: The units convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. F2 · derivative.expiration_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. Read SEC document
May 26, 2021 Filed May 28, 2021 20:32 UTC	Elevance Health, Inc. ANTM · Entity 2934	GrantCommon Stock	493	$0.00	$0.00	Disclosure SEC source: 0001156039-21-000062 · wf-form4_162223389478151.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,006 F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document
May 20, 2021 Filed May 21, 2021 18:11 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	SaleCommon Stock	22,800	$64.94	$1,480,632.00	Disclosure SEC source: 0001126328-21-000153 · edgar.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Retired Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,432 F1 · kind: Effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 30, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.48 to $65.39, inclusive. The reporting person undertakes to provide Principal Financial Group, Inc., any security holder of Principal Financial Group, Inc., or the staff of the Securities Exchanges Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document
April 28, 2021 Filed Apr 30, 2021 20:14 UTC	Moderna, Inc. MRNA · Entity 2025	GrantRestricted Stock Units · Derivative	703	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001127602-21-014778 · form4.xml · derivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 703 Underlying: Common Stock · 703 shares Expires not disclosed F2 · derivative.exercise_date: The shares subject to this restricted stock unit award will vest in full on the earlier of April 28, 2022, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. F2 · derivative.expiration_date: The shares subject to this restricted stock unit award will vest in full on the earlier of April 28, 2022, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document
April 28, 2021 Filed Apr 30, 2021 20:14 UTC	Moderna, Inc. MRNA · Entity 2025	GrantStock Option (Right to Buy) · Derivative	4,081	$0.00 Strike: $178.68	$0.00	Disclosure SEC source: 0001127602-21-014778 · form4.xml · derivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,081 Underlying: Common Stock · 4,081 shares Expires 2031-04-28 F1 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of April 28, 2022, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document
March 26, 2021 Filed Mar 30, 2021 20:52 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantPhantom Stock Units · Derivative	73	$60.63	$4,425.99	Disclosure SEC source: 0001126328-21-000128 · edgar.xml · derivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,051 Underlying: Common Stock · 73 shares Expires not disclosed F2 · derivative.exercise_price: The units convert to common stock on a one-for-one basis. F3 · derivative.exercise_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. F3 · derivative.expiration_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. Read SEC document
March 26, 2021 Filed Mar 30, 2021 20:52 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantCommon Stock	596	$0.00	$0.00	Disclosure SEC source: 0001126328-21-000128 · edgar.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,232 F1 · price: Grant of restricted stock units. Read SEC document
December 21, 2020 Filed Dec 23, 2020 19:58 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantPhantom Stock Units · Derivative	93	$47.50	$4,417.50	Disclosure SEC source: 0001126328-20-000232 · edgar.xml · derivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,978 Underlying: Common Stock · 93 shares Expires not disclosed F2 · derivative.exercise_price: The units convert to common stock on a one-for-one basis. F3 · derivative.exercise_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. F3 · derivative.expiration_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. Read SEC document
December 21, 2020 Filed Dec 23, 2020 19:58 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantCommon Stock	752	$0.00	$0.00	Disclosure SEC source: 0001126328-20-000232 · edgar.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,636 F1 · price: Grant of restricted stock units. Read SEC document
November 11, 2020 Filed Nov 13, 2020 19:44 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	GrantStock equivalent units · Derivative	5,118	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000065011-20-000145 · wf-form4_160531463116109.xml · derivative · entry 3 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,282 Underlying: Common Stock ($1 par value) · 5,118 shares Expires not disclosed F3 · derivative.exercise_date: Stock equivalent units issued pursuant to the Meredith Corporation 2014 Stock Incentive Plan, which will be converted to Common Stock ($1 par value) on a one-for-one basis upon the reporting person's retirement from or termination of service on the Meredith Board of Directors. Quarterly dividends, to the extent they are paid by the Company, are accrued in the form of additional stock equivalents. F3 · derivative.expiration_date: Stock equivalent units issued pursuant to the Meredith Corporation 2014 Stock Incentive Plan, which will be converted to Common Stock ($1 par value) on a one-for-one basis upon the reporting person's retirement from or termination of service on the Meredith Board of Directors. Quarterly dividends, to the extent they are paid by the Company, are accrued in the form of additional stock equivalents. Read SEC document
November 11, 2020 Filed Nov 13, 2020 19:44 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	GrantNon-Qualified Stock Option (right to buy) · Derivative	11,692	$0.00 Strike: $15.90	$0.00	Disclosure SEC source: 0000065011-20-000145 · wf-form4_160531463116109.xml · derivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,692 Underlying: Common Stock ($1 par value) · 11,692 shares Expires 2030-11-11 F2 · derivative.exercise_date: Nonqualified stock options awarded pursuant to the Meredith Corporation 2014 Stock Incentive Plan, which become exercisable one-third per year over a three-year period beginning on the first anniversary of the grant date. Read SEC document
November 11, 2020 Filed Nov 13, 2020 19:44 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	GrantCommon Stock ($1 par value)	4,246	$0.00	$0.00	Disclosure SEC source: 0000065011-20-000145 · wf-form4_160531463116109.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,694 F1 · shares: This restricted stock was awarded pursuant to the Meredith Corporation 2014 Stock Incentive Plan. The shares are subject to forfeiture and non-transferable until vested. Restrictions on the shares lapse on 1/3 of the shares per year commencing on the first anniversary of the grant date. Read SEC document
September 25, 2020 Filed Sep 29, 2020 20:28 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantPhantom Stock Units · Derivative	113	$38.63	$4,365.19	Disclosure SEC source: 0001126328-20-000191 · edgar.xml · derivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,885 Underlying: Common Stock · 113 shares Expires not disclosed F2 · derivative.exercise_price: The units convert to common stock on a one-for-one basis. F3 · derivative.exercise_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. F3 · derivative.expiration_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. Read SEC document
September 25, 2020 Filed Sep 29, 2020 20:28 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantCommon Stock	916	$0.00	$0.00	Disclosure SEC source: 0001126328-20-000191 · edgar.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,884 F1 · price: Grant of restricted stock units. Read SEC document
July 01, 2020 Filed Jul 2, 2020 20:48 UTC	Moderna, Inc. MRNA · Entity 2025	GrantStock Option (Right to Buy) · Derivative	11,229	$61.59 Strike: $61.59	$691,594.11	Disclosure SEC source: 0001127602-20-020955 · form4.xml · derivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,229 Underlying: Common Stock · 11,229 shares Expires 2030-07-01 F2 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of April 29, 2021, or the next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document
July 01, 2020 Filed Jul 2, 2020 20:48 UTC	Moderna, Inc. MRNA · Entity 2025	GrantStock Option (Right to Buy) · Derivative	12,590	$61.59 Strike: $61.59	$775,418.10	Disclosure SEC source: 0001127602-20-020955 · form4.xml · derivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,590 Underlying: Common Stock · 12,590 shares Expires 2030-07-01 F1 · derivative.exercise_date: This option will be fully vested and exercisable on July 1, 2021. Read SEC document
June 26, 2020 Filed Jun 30, 2020 22:39 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantPhantom Stock Units · Derivative	109.6	$39.14	$4,289.74	Disclosure SEC source: 0001126328-20-000145 · primary_doc.xml · derivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,772 Underlying: Common Stock · 109.6 shares Expires not disclosed F2 · derivative.exercise_price: The units convert to common stock on a one-for-one basis. F3 · derivative.exercise_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. F3 · derivative.expiration_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. Read SEC document
June 26, 2020 Filed Jun 30, 2020 22:39 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantCommon Stock	887	Not disclosed	Not disclosed	Disclosure SEC source: 0001126328-20-000145 · primary_doc.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,968 F1 · price: Grant of restricted stock units Read SEC document
May 21, 2020 Filed May 26, 2020 20:35 UTC	Elevance Health, Inc. ANTM · Entity 2934	GrantCommon Stock	699	$0.00	$0.00	Disclosure SEC source: 0001156039-20-000047 · wf-form4_159052528312965.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,513 F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document
May 19, 2020 Filed May 21, 2020 19:30 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantCommon Stock	4,674	$0.00	$0.00	Disclosure SEC source: 0001126328-20-000137 · edgar.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,081 F1 · price: Grant of restricted stock units. Read SEC document
March 27, 2020 Filed Mar 31, 2020 19:27 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantPhantom Stock Units · Derivative	129.4	$32.60	$4,218.44	Disclosure SEC source: 0001126328-20-000106 · edgar.xml · derivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,662 Underlying: Common Stock · 129.4 shares Expires not disclosed F2 · derivative.exercise_price: The units convert to common stock on a one-for-one basis. F3 · derivative.exercise_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. F3 · derivative.expiration_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. Read SEC document
March 27, 2020 Filed Mar 31, 2020 19:27 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantCommon Stock	968	$0.00	$0.00	Disclosure SEC source: 0001126328-20-000106 · edgar.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,407 F1 · price: Grant of restricted stock units. Read SEC document
December 27, 2019 Filed Dec 31, 2019 21:08 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantPhantom Stock Units · Derivative	72.8	$54.76	$3,986.53	Disclosure SEC source: 0001126328-19-000268 · edgar.xml · derivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,533 Underlying: Common Stock · 72.8 shares Expires not disclosed F2 · derivative.exercise_price: The units convert to common stock on a one-for-one basis. F3 · derivative.exercise_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. F3 · derivative.expiration_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. Read SEC document
December 27, 2019 Filed Dec 31, 2019 21:08 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantCommon Stock	560	$0.00	$0.00	Disclosure SEC source: 0001126328-19-000268 · edgar.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,439 F1 · price: Grant of restricted stock units. Read SEC document
December 05, 2019 Filed Dec 6, 2019 21:03 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantPhantom Stock Units · Derivative	24.4	$52.79	$1,288.08	Disclosure SEC source: 0001126328-19-000252 · edgar.xml · derivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,458.4 Underlying: Common Stock · 24.4 shares Expires not disclosed F1 · derivative.exercise_price: The units convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. F2 · derivative.expiration_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. Read SEC document
November 13, 2019 Filed Nov 15, 2019 14:53 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	GrantNon-Qualified Stock Option (right to buy) · Derivative	8,161	$0.00 Strike: $35.39	$0.00	Disclosure SEC source: 0000065011-19-000127 · wf-form4_157384758936112.xml · derivative · entry 3 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,161 Underlying: Common Stock ($1 par value) · 8,161 shares Expires 2029-11-13 F4 · derivative.exercise_date: Nonqualified stock options awarded pursuant to the Meredith Corporation 2014 Stock Incentive Plan, which become exercisable one-third per year over a three-year period beginning on the first anniversary of the grant date. Read SEC document
November 13, 2019 Filed Nov 15, 2019 14:53 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	GrantStock equivalent units · Derivative	1,855	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000065011-19-000127 · wf-form4_157384758936112.xml · derivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,328 Underlying: Common Stock ($1 par value) · 1,855 shares Expires not disclosed F3 · derivative.exercise_date: Stock equivalent units issued pursuant to the Meredith Corporation 2014 Stock Incentive Plan, which will be converted to Common Stock ($1 par value) on a one-for-one basis upon the reporting person's retirement from or termination of service on the Meredith Board of Directors. Quarterly dividends are accrued in the form of additional stock equivalents. F3 · derivative.expiration_date: Stock equivalent units issued pursuant to the Meredith Corporation 2014 Stock Incentive Plan, which will be converted to Common Stock ($1 par value) on a one-for-one basis upon the reporting person's retirement from or termination of service on the Meredith Board of Directors. Quarterly dividends are accrued in the form of additional stock equivalents. Read SEC document
November 13, 2019 Filed Nov 15, 2019 14:53 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	GrantCommon Stock ($1 par value)	1,908	$0.00	$0.00	Disclosure SEC source: 0000065011-19-000127 · wf-form4_157384758936112.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,105 F1 · shares: This restricted stock award was awarded pursuant to the Meredith Corporation 2014 Stock Incentive Plan. The share are subject to forfeiture and non-transferable until vested. Restrictions on the shares lapse on 1/3 of the shares per year commencing on the first anniversary of the grant date. F2 · balance_after: Shares held by the reporting person in street name and in a registered account in the reporting persons name. Read SEC document
September 27, 2019 Filed Oct 1, 2019 20:01 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantPhantom Stock Units · Derivative	70.6	$57.37	$4,050.32	Disclosure SEC source: 0001126328-19-000225 · edgar.xml · derivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,434 Underlying: Common Stock · 70.6 shares Expires not disclosed F2 · derivative.exercise_price: The units convert to common stock on a one-for-one basis. F3 · derivative.exercise_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. F3 · derivative.expiration_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. Read SEC document
September 27, 2019 Filed Oct 1, 2019 20:01 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantCommon Stock	530	$0.00	$0.00	Disclosure SEC source: 0001126328-19-000225 · edgar.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,879 F1 · price: Grant of restricted stock units. Read SEC document
September 13, 2019 Filed Sep 17, 2019 17:27 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	PurchaseCommon Stock ($1 par value)	1,250	$37.45	$46,811.75	Disclosure SEC source: 0000065011-19-000087 · wf-form4_156875560666054.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,197 F1 · price: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide Meredith, any securityholder of Meredith Corporation, or the Staff of the Securities and Exchange Commission, upon request, separate prices within the range set forth in footnote (1) to this Form 4. F2 · balance_after: Common stock includes restricted shares and shares held by the reporting person in a street name account. Read SEC document
June 28, 2019 Filed Jul 2, 2019 20:59 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantPhantom Stock Units · Derivative	66.5	$57.92	$3,851.68	Disclosure SEC source: 0001126328-19-000187 · edgar.xml · derivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,363.4 Underlying: Common Stock · 66.5 shares Expires not disclosed F3 · derivative.exercise_price: The units convert to common stock on a one-for-one basis. F4 · derivative.exercise_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. F4 · derivative.expiration_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. Read SEC document
June 28, 2019 Filed Jul 2, 2019 20:59 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantCommon Stock	510	$0.00	$0.00	Disclosure SEC source: 0001126328-19-000187 · edgar.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,349 F1 · price: Grant of restricted stock units. F2 · balance_after: Corrects prior inadvertent administrative error. Read SEC document
May 31, 2019 Filed Jun 3, 2019 18:12 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantPhantom Stock Units · Derivative	60.6	$51.57	$3,125.14	Disclosure SEC source: 0001126328-19-000169 · edgar.xml · derivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,295.9 Underlying: Common Stock · 60.6 shares Expires not disclosed F1 · derivative.exercise_price: The units convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. F2 · derivative.expiration_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. Read SEC document
May 21, 2019 Filed May 23, 2019 19:36 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantCommon Stock	2,982	$0.00	$0.00	Disclosure SEC source: 0001126328-19-000165 · edgar.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,820 F1 · price: Grant of restricted stock units. Read SEC document
May 15, 2019 Filed May 17, 2019 20:21 UTC	Elevance Health, Inc. ANTM · Entity 2934	GrantCommon Stock	753	$0.00	$0.00	Disclosure SEC source: 0001127602-19-018997 · form4.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,814 F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program. F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. Read SEC document
March 29, 2019 Filed Apr 2, 2019 21:08 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantPhantom Stock Units · Derivative	77	$50.19	$3,864.63	Disclosure SEC source: 0001126328-19-000121 · edgar.xml · derivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,235.3 Underlying: Common Stock · 77 shares Expires not disclosed F2 · derivative.exercise_price: The units convert to common stock on a one-for-one basis. F3 · derivative.exercise_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. F3 · derivative.expiration_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. Read SEC document
March 29, 2019 Filed Apr 2, 2019 21:08 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantCommon Stock	551	$0.00	$0.00	Disclosure SEC source: 0001126328-19-000121 · edgar.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,838 F1 · price: Grant of restricted stock units. Read SEC document
December 28, 2018 Filed Jan 2, 2019 21:51 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantPhantom Stock Units · Derivative	86.8	$43.56	$3,781.01	Disclosure SEC source: 0001126328-19-000010 · edgar.xml · derivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,158.3 Underlying: Common Stock · 86.8 shares Expires not disclosed F2 · derivative.exercise_price: The units convert to common stock on a one-for-one basis. F3 · derivative.exercise_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. F3 · derivative.expiration_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. Read SEC document
December 28, 2018 Filed Jan 2, 2019 21:51 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantCommon Stock	627	$0.00	$0.00	Disclosure SEC source: 0001126328-19-000010 · edgar.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,287 F1 · price: Grant of restricted stock units. Read SEC document
December 06, 2018 Filed Dec 7, 2018 19:19 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantPhantom Stock Units · Derivative	69.4	$45.03	$3,125.08	Disclosure SEC source: 0001126328-18-000303 · edgar.xml · derivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,071.5 Underlying: Common Stock · 69.4 shares Expires not disclosed F1 · derivative.exercise_price: The units convert to common stock on a one-for-one basis. F2 · derivative.exercise_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. F2 · derivative.expiration_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. Read SEC document
November 14, 2018 Filed Nov 16, 2018 17:52 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	GrantStock equivalent units · Derivative	1,119	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000065011-18-000149 · wf-form4_154240873357720.xml · derivative · entry 3 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,680 Underlying: Common Stock ($1 par value) · 1,119 shares Expires not disclosed F4 · derivative.exercise_date: Stock equivalent units issued pursuant to the Meredith Corporation 2014 Stock Incentive Plan, which will be converted to Common Stock ($1 par value) on a one-for-one basis upon the reporting person's retirement from or termination of service on the Meredith Board of Directors. Quarterly dividends are accrued in the form of additional stock equivalents. F4 · derivative.expiration_date: Stock equivalent units issued pursuant to the Meredith Corporation 2014 Stock Incentive Plan, which will be converted to Common Stock ($1 par value) on a one-for-one basis upon the reporting person's retirement from or termination of service on the Meredith Board of Directors. Quarterly dividends are accrued in the form of additional stock equivalents. Read SEC document
November 14, 2018 Filed Nov 16, 2018 17:52 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	GrantNon-Qualified Stock Option (right to buy) · Derivative	3,827	$58.69 Strike: $58.69	$224,606.63	Disclosure SEC source: 0000065011-18-000149 · wf-form4_154240873357720.xml · derivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,827 Underlying: Common Stock ($1 par value) · 3,827 shares Expires 2028-11-14 F3 · derivative.exercise_date: Nonqualified stock options awarded pursuant to the Meredith Corporation 2014 Stock Incentive Plan, which become exercisable one-third per year over a three-year period beginning on the first anniversary of the grant date and expire on the tenth anniversary of the grant date. Read SEC document
November 14, 2018 Filed Nov 16, 2018 17:52 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	GrantCommon Stock ($1 par value)	938	$0.00	$0.00	Disclosure SEC source: 0000065011-18-000149 · wf-form4_154240873357720.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,390 F1 · shares: This restricted stock was awarded pursuant to the Meredith Corporation 2014 Stock Incentive Plan. The shares are subject to forfeiture and non-transferable until vested. Restrictions on the shares lapse on 1/3 of the shares per year commencing on the first anniversary of the grant date. F2 · balance_after: Common stock includes restricted shares and shares held by the reporting person in a street name account. Read SEC document
November 14, 2018 Filed Nov 20, 2018 17:55 UTC Amendment	Hawkeye Acquisition, Inc. MDP · Entity 132775	GrantNon-Qualified Stock Option (right to buy) · Derivative	4,697	$58.69 Strike: $58.69	$275,666.93	Disclosure SEC source: 0000065011-18-000171 · wf-form4a_154275453174184.xml · derivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,697 Underlying: Common Stock ($1 par value) · 4,697 shares Expires 2028-11-14 F3 · derivative.exercise_date: Nonqualified stock options awarded pursuant to the Meredith Corporation 2014 Stock Incentive Plan, which become exercisable one-third per year over a three-year period beginning on the first anniversary of the grant date and expire on the tenth anniversary of the grant date. Read SEC document
November 14, 2018 Filed Nov 20, 2018 17:55 UTC Amendment	Hawkeye Acquisition, Inc. MDP · Entity 132775	GrantCommon Stock ($1 par value)	1,151	$0.00	$0.00	Disclosure SEC source: 0000065011-18-000171 · wf-form4a_154275453174184.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,603 F1 · shares: This restricted stock was awarded pursuant to the Meredith Corporation 2014 Stock Incentive Plan. The shares are subject to forfeiture and non-transferable until vested. Restrictions on the shares lapse on 1/3 of the shares per year commencing on the first anniversary of the grant date. F2 · balance_after: Common stock includes restricted shares and shares held by the reporting person in a street name account. Read SEC document
September 28, 2018 Filed Oct 2, 2018 20:19 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantPhantom Stock Units · Derivative	62.8	$58.59	$3,679.45	Disclosure SEC source: 0001126328-18-000257 · edgar.xml · derivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,002.1 Underlying: Common Stock · 62.8 shares Expires not disclosed F2 · derivative.exercise_price: The units convert to common stock on a one-for-one basis. F3 · derivative.exercise_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. F3 · derivative.expiration_date: The reported phantom stock units were acquired pursuant to the Principal Deferred Compensation Plan for Non-Employee Directors and will be settled on the reporting person's retirement. Read SEC document
September 28, 2018 Filed Oct 2, 2018 20:19 UTC	PRINCIPAL FINANCIAL GROUP INC PFG · Entity 3209	GrantCommon Stock	453	$0.00	$0.00	Disclosure SEC source: 0001126328-18-000257 · edgar.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,660 F1 · price: Grant of restricted stock units. Read SEC document
September 06, 2018 Filed Sep 7, 2018 16:44 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative	6,000	$0.00 Strike: $18.56	$0.00	Disclosure SEC source: 0000065011-18-000114 · wf-form4_153635306532691.xml · derivative · entry 3 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock ($1 par value) · 6,000 shares Expires 2018-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Nonqualified stock options awarded pursuant to the Meredith Corporation 2004 Stock Incentive Plan, which become exercisable one-third per year over a three-year period beginning on the first anniversary of the grant date. Read SEC document
September 06, 2018 Filed Sep 7, 2018 16:44 UTC	Hawkeye Acquisition, Inc. MDP · Entity 132775	Tax withholdingCommon Stock ($1 par value)	2,184	$51.00	$111,384.00	Disclosure SEC source: 0000065011-18-000114 · wf-form4_153635306532691.xml · nonDerivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,452 F1 · security: Common stock includes restricted shares and shares held by the reporting person in a street name account. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.